Rheumatology Center

Houston's #1 Rheumatologist

syringe penetrating vial
21Aug, 2017

Pharmaceutical Pricing Wars Have Begun

By: | Tags:

In a bold move, Merck & Co., Inc., recently launched Renflexis, a biosimilar to Johnson and Johnson’s well-known Remicade. Merck is an American pharmaceutical company based in Kenilworth, New Jersey, however, Renflexis was developed by the Korean drugmaker, Samsung Bioepis. Merck has announced the price for their biosimilar at a 35% discount compared to Remicade’s wholesale acquisition cost.   Setting the price of Renflexis this low in the U.S. market appears to be creating quite a stir in the pharmaceutical market. Especially after Pfizer Inc., in partnership with Celltrion, launched […]
READ MORE

30Mar, 2016

Congress Hears Lupus Advocates

By: | Tags:

  Today members of Congress as well as other key U.S. legislators will be educated by 50 patient advocates from the Alliance for Lupus Research and The Lupus Research Institute. This session will be hosting virtual advocates who where not able to make it. The added benefit of technology is expected to boost numbers up to 50,000 advocates who will call or email to help make a louder statement for our loved ones affected by Lupus. You can help by: – Emailing your legislators directly through our Legislative Action Center. […]
READ MORE

24Nov, 2015

RDCH & GSK Partner for Patient Success

By: | Tags:

Houston, TX – November 13, 2015- The Rheumatic Disease Clinic of Houston (RDCH) announces its newly formed partnership with London-based multinational pharmaceutical company GSK to further research and treatment of Rheumatic disease . RDCH serves student athletes, family and elderly patients suffering from inflammation to the body’s tissues. GSK will provide RDCH with up-to-the-minute information and news on clinical trials, research, drug and therapy options, new management apps, supplementary materials for patients and additional resources. Their aim is to educate patients suffering from Rheumatic Disease and allow them to become […]
READ MORE

28Jul, 2015

Big Government Update Hampers Doctors

By: | Tags:

*Originally Published in the Houston Chronicle The never-ending siege waged by the Center for Medicare Services (CMS) against the private practice of medicine in our country has physicians facing a new bureaucratic hurdle: the rapidly approaching implementation of a new version of ICD-10 (International Classification of Diseases-Version 10). The ICD system is a set of codes that all physicians must use to notate a disease “process” for which they have rendered care—and the diagnosis—in order for them to be reimbursed for that service. The current system already is quite cumbersome, […]
READ MORE